Hims & Hers Health (HIMS) Interest & Investment Income (2019 - 2020)

Hims & Hers Health (HIMS) posted Interest & Investment Income of $36858.0 for Q2 2020, down 97.67% sequentially from $1.6 million in Q1 2020.

Hims & Hers Health (HIMS) Interest & Investment Income (2019 - 2020) Analysis & Trends

Hims & Hers Health has reported Interest & Investment Income for 2 years, with the latest figure at $36858.0 in Q2 2020.

Quarterly Interest & Investment Income changed N/A year-over-year to $36858.0 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $4.4 million (changed N/A YoY) and the FY2019 annual result came in at $1.9 million, changed N/A from the prior year.
Interest & Investment Income declined to $36858.0 in Q2 2020 per HIMS's latest filing, from $1.6 million in the prior quarter.
Over five years, Interest & Investment Income peaked at $1.9 million in Q4 2019 and troughed at $36858.0 in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	154.39 Mn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	31.50 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	12.40 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Hims & Hers Health	7.42 Bn	6.57 Bn	480.80 Mn	-

Download Data